Caselmann WH - Search Results

1

Sauerbruch T, Caselmann WH, Spengler U. Sauerbruch T, et al. Among authors: caselmann wh. Eur J Gastroenterol Hepatol. 1999 Jan;11(1):41-6. doi: 10.1097/00042737-199901000-00009. Eur J Gastroenterol Hepatol. 1999. PMID: 10495171 Review. No abstract available.

2

[Liver cirrhosis--1: Pathogenesis and diagnosis].

Rabe C, Heller J, Sauerbruch T, Caselmann WH. Rabe C, et al. Among authors: caselmann wh. Dtsch Med Wochenschr. 2001 Sep 7;126(36):975-7; quiz 982-3. doi: 10.1055/s-2001-16961. Dtsch Med Wochenschr. 2001. PMID: 11544549 German. No abstract available.

3

[Liver cirrhosis--2: Complications and treatment].

Schepke M, Reichel C, Ziske C, Spengler U, Caselmann WH, Sauerbruch T. Schepke M, et al. Among authors: caselmann wh. Dtsch Med Wochenschr. 2001 Sep 7;126(36):978-81; quiz 982-4. doi: 10.1055/s-2001-16962. Dtsch Med Wochenschr. 2001. PMID: 11544550 German. No abstract available.

4

Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.

Rabe C, Pilz T, Klostermann C, Berna M, Schild HH, Sauerbruch T, Caselmann WH. Rabe C, et al. Among authors: caselmann wh. World J Gastroenterol. 2001 Apr;7(2):208-15. doi: 10.3748/wjg.v7.i2.208. World J Gastroenterol. 2001. PMID: 11819762 Free PMC article.

5

Cirrhotic patients with or without hepatocellular carcinoma harbour AFP-specific T-lymphocytes that can be activated in vitro by human alpha-fetoprotein.

Hanke P, Rabe C, Serwe M, Böhm S, Pagenstecher C, Sauerbruch T, Caselmann WH. Hanke P, et al. Among authors: caselmann wh. Scand J Gastroenterol. 2002 Aug;37(8):949-55. doi: 10.1080/003655202760230928. Scand J Gastroenterol. 2002. PMID: 12229971

6

[Liver cirrhosis as precancerous conditions].

Caselmann WH, Spengler U, Fischer HP, Sauerbruch T. Caselmann WH, et al. Internist (Berl). 1997 Oct;38(10):928-36. doi: 10.1007/s001080050103. Internist (Berl). 1997. PMID: 9432500 Review. German. No abstract available.

7

Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension.

Schepke M, Werner E, Biecker E, Schiedermaier P, Heller J, Neef M, Stoffel-Wagner B, Hofer U, Caselmann WH, Sauerbruch T. Schepke M, et al. Among authors: caselmann wh. Gastroenterology. 2001 Aug;121(2):389-95. doi: 10.1053/gast.2001.26295. Gastroenterology. 2001. PMID: 11487548 Clinical Trial.

8

Treatment of metastatic colorectal carcinomas by systemic inhibition of vascular endothelial growth factor signaling in mice.

Schmitz V, Kornek M, Hilbert T, Dzienisowicz C, Raskopf E, Rabe C, Sauerbruch T, Qian C, Caselmann WH. Schmitz V, et al. Among authors: caselmann wh. World J Gastroenterol. 2005 Jul 28;11(28):4332-6. doi: 10.3748/wjg.v11.i28.4332. World J Gastroenterol. 2005. PMID: 16038030 Free PMC article.

9

Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.

Schmitz V, Vilanueva H, Raskopf E, Hilbert T, Barajas M, Dzienisowicz C, Gorschlüter M, Strehl J, Rabe C, Sauerbruch T, Prieto J, Caselmann WH, Qian C. Schmitz V, et al. Among authors: caselmann wh. Gene Ther. 2006 Aug;13(16):1198-205. doi: 10.1038/sj.gt.3302772. Epub 2006 Apr 13. Gene Ther. 2006. PMID: 16617302

10

Clinical outcome of a cohort of 63 patients with hepatocellular carcinoma treated with octreotide.

Rabe C, Pilz T, Allgaier HP, Halm U, Strasser C, Wettstein M, Sauerbruch T, Caselmann WH. Rabe C, et al. Among authors: caselmann wh. Z Gastroenterol. 2002 Jun;40(6):395-400. doi: 10.1055/s-2002-32129. Z Gastroenterol. 2002. PMID: 12055662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page